KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Invested Capital (2016 - 2025)

Historic Invested Capital for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $42.7 million.

  • Inovio Pharmaceuticals' Invested Capital fell 4198.55% to $42.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.7 million, marking a year-over-year decrease of 4198.55%. This contributed to the annual value of $81.8 million for FY2024, which is 3904.03% down from last year.
  • According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Invested Capital is $42.7 million, which was down 4198.55% from $40.0 million recorded in Q2 2025.
  • Inovio Pharmaceuticals' Invested Capital's 5-year high stood at $582.4 million during Q1 2021, with a 5-year trough of $40.0 million in Q2 2025.
  • In the last 5 years, Inovio Pharmaceuticals' Invested Capital had a median value of $186.1 million in 2023 and averaged $224.9 million.
  • Per our database at Business Quant, Inovio Pharmaceuticals' Invested Capital soared by 20958.0% in 2021 and then plummeted by 5870.21% in 2025.
  • Over the past 5 years, Inovio Pharmaceuticals' Invested Capital (Quarter) stood at $400.2 million in 2021, then tumbled by 44.44% to $222.4 million in 2022, then tumbled by 39.68% to $134.1 million in 2023, then plummeted by 39.04% to $81.8 million in 2024, then tumbled by 47.82% to $42.7 million in 2025.
  • Its Invested Capital stands at $42.7 million for Q3 2025, versus $40.0 million for Q2 2025 and $60.8 million for Q1 2025.